HIVE Blockchain Technologies (CVE:HIV – Get Free Report) was downgraded by research analysts at Keefe, Bruyette & Woods from a “moderate buy” rating to a “hold” rating in a research report issued on Tuesday,Zacks.com reports.
Separately, B. Riley upgraded HIVE Blockchain Technologies to a “strong-buy” rating in a research note on Friday, November 21st. Two equities research analysts have rated the stock with a Strong Buy rating and one has assigned a Hold rating to the stock. According to data from MarketBeat, HIVE Blockchain Technologies has an average rating of “Buy”.
View Our Latest Analysis on HIV
HIVE Blockchain Technologies Price Performance
Further Reading
- Five stocks we like better than HIVE Blockchain Technologies
- America’s Next Power Move Starts Underground
- Your Signature Is Missing – Act Before It’s Too Late
- NEW LAW: Congress Approves Setup For Digital Dollar?
- BSEM: A $25.50 Price Target, and Nasdaq on the Horizon!
- URGENT: Trump Just Triggered AI’s Biggest Disruption Yet
Receive News & Ratings for HIVE Blockchain Technologies Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HIVE Blockchain Technologies and related companies with MarketBeat.com's FREE daily email newsletter.
